speb/financial-data huggingface dataset:
EMR.V cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 454236.00
EMR.V cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 104485.00
EMR.V cash_flow (annual, 2023-12-31) — Change In Receivables: 98128.00
EMR.V cash_flow (annual, 2023-12-31) — Change In Working Capital: 656849.00
EMR.V cash_flow (annual, 2023-12-31) — Changes In Cash: -463599.00
EMR.V balance_sheet (annual, 2023-12-31) — Common Stock: 49111305.00
EMR.V balance_sheet (annual, 2023-12-31) — Common Stock Equity: 986529.00
EMR.V cash_flow (annual, 2023-12-31) — Common Stock Issuance: 390777.00
EMR.V income_statement (annual, 2023-12-31) — Cost Of Revenue: 23659.00
EMR.V balance_sheet (annual, 2023-12-31) — Current Assets: 357298.00
EMR.V balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 0.00
EMR.V balance_sheet (annual, 2023-12-31) — Current Debt: 26603.00
EMR.V balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 26603.00
EMR.V balance_sheet (annual, 2023-12-31) — Current Liabilities: 1931567.00
EMR.V cash_flow (annual, 2023-12-31) — Depreciation: 23659.00
EMR.V cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 23659.00
EMR.V cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 23659.00
EMR.V income_statement (annual, 2023-12-31) — Diluted Average Shares: 27776214.00
EMR.V income_statement (annual, 2023-12-31) — Diluted EPS: -0.03
EMR.V income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -826251.00
EMR.V balance_sheet (annual, 2023-12-31) — Dueto Related Parties Current: 233038.00
EMR.V income_statement (annual, 2023-12-31) — EBIT: -825000.00
EMR.V income_statement (annual, 2023-12-31) — EBITDA: -801341.00
EMR.V cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 0.00
EMR.V cash_flow (annual, 2023-12-31) — End Cash Position: 224525.00
EMR.V cash_flow (annual, 2023-12-31) — Financing Cash Flow: 439663.00
EMR.V cash_flow (annual, 2023-12-31) — Free Cash Flow: -1151315.00
EMR.V cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -1135494.00
EMR.V income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: 0.00
EMR.V income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 1171880.00
EMR.V income_statement (annual, 2023-12-31) — General And Administrative Expense: 789356.00
EMR.V balance_sheet (annual, 2023-12-31) — Gross PPE: 2677353.00
EMR.V income_statement (annual, 2023-12-31) — Gross Profit: -23659.00
EMR.V income_statement (annual, 2023-12-31) — Insurance And Claims: 31198.00
EMR.V income_statement (annual, 2023-12-31) — Interest Expense: 1251.00
EMR.V income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 1251.00
EMR.V balance_sheet (annual, 2023-12-31) — Invested Capital: 1013132.00
EMR.V cash_flow (annual, 2023-12-31) — Investing Cash Flow: 194779.00
EMR.V cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 390777.00
EMR.V cash_flow (annual, 2023-12-31) — Issuance Of Debt: 26303.00
EMR.V cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -18093.00
EMR.V balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 95012.00
EMR.V cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 390777.00
EMR.V cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 4592.00
EMR.V income_statement (annual, 2023-12-31) — Net Income: -826251.00
EMR.V income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -826251.00
EMR.V income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -826251.00
EMR.V income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -826251.00
EMR.V income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -826251.00
EMR.V cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -826251.00
EMR.V income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -826251.00
EMR.V income_statement (annual, 2023-12-31) — Net Interest Income: -3083.00
EMR.V cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 182753.00
EMR.V cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 8210.00
EMR.V cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -18093.00
EMR.V income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -3083.00
EMR.V cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 300.00
EMR.V cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 65000.00
EMR.V balance_sheet (annual, 2023-12-31) — Net PPE: 2560798.00
EMR.V cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -52974.00
EMR.V cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 26303.00
EMR.V balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 986529.00
EMR.V balance_sheet (annual, 2023-12-31) — Non Current Prepaid Assets: 0.00
EMR.V income_statement (annual, 2023-12-31) — Normalized EBITDA: -1895397.00
EMR.V income_statement (annual, 2023-12-31) — Normalized Income: -1920307.00
EMR.V cash_flow (annual, 2023-12-31) — Operating Cash Flow: -1098341.00
EMR.V cash_flow (annual, 2023-12-31) — Operating Gains Losses: -1130902.00
EMR.V income_statement (annual, 2023-12-31) — Operating Income: -1953351.00
EMR.V income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
EMR.V balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 32108670.00
EMR.V balance_sheet (annual, 2023-12-31) — Other Current Assets: -246.00
EMR.V balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 26603.00
EMR.V balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 335209.00
EMR.V balance_sheet (annual, 2023-12-31) — Other Equity Interest: 9077555.00
EMR.V income_statement (annual, 2023-12-31) — Other Gand A: 559658.00
EMR.V income_statement (annual, 2023-12-31) — Other Income Expense: 1130183.00
EMR.V cash_flow (annual, 2023-12-31) — Other Non Cash Items: -34876.00
EMR.V income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 36127.00
EMR.V income_statement (annual, 2023-12-31) — Other Operating Expenses: 836369.00
EMR.V balance_sheet (annual, 2023-12-31) — Other Properties: 2582341.00
EMR.V balance_sheet (annual, 2023-12-31) — Other Receivables: 34000.00
EMR.V balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 0.00
EMR.V income_statement (annual, 2023-12-31) — Other Special Charges: -39038.00
EMR.V income_statement (annual, 2023-12-31) — Other Taxes: 303967.00
EMR.V balance_sheet (annual, 2023-12-31) — Payables: 1569755.00
EMR.V balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 1569755.00
EMR.V balance_sheet (annual, 2023-12-31) — Prepaid Assets: 45019.00
EMR.V income_statement (annual, 2023-12-31) — Pretax Income: -826251.00
EMR.V cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 40676.00
EMR.V cash_flow (annual, 2023-12-31) — Purchase Of PPE: -52974.00
EMR.V balance_sheet (annual, 2023-12-31) — Receivables: 88000.00
EMR.V income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 23659.00
EMR.V income_statement (annual, 2023-12-31) — Reconciled Depreciation: 23659.00
EMR.V income_statement (annual, 2023-12-31) — Rent And Landing Fees: 13553.00
EMR.V income_statement (annual, 2023-12-31) — Rent Expense Supplemental: 13553.00
EMR.V cash_flow (annual, 2023-12-31) — Repayment Of Debt: -18093.00
EMR.V balance_sheet (annual, 2023-12-31) — Retained Earnings: -57202331.00
EMR.V income_statement (annual, 2023-12-31) — Salaries And Wages: 184947.00
EMR.V cash_flow (annual, 2023-12-31) — Sale Of Investment: 182753.00
EMR.V cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
EMR.V income_statement (annual, 2023-12-31) — Selling General And Administration: 789356.00
EMR.V balance_sheet (annual, 2023-12-31) — Share Issued: 32108670.00
EMR.V cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 26303.00
EMR.V income_statement (annual, 2023-12-31) — Special Income Charges: -77824.00
EMR.V cash_flow (annual, 2023-12-31) — Stock Based Compensation: 184947.00
EMR.V balance_sheet (annual, 2023-12-31) — Stockholders Equity: 986529.00
EMR.V balance_sheet (annual, 2023-12-31) — Tangible Book Value: 986529.00
EMR.V income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
EMR.V income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
EMR.V balance_sheet (annual, 2023-12-31) — Taxes Receivable: 54000.00
EMR.V balance_sheet (annual, 2023-12-31) — Total Assets: 2918096.00
EMR.V balance_sheet (annual, 2023-12-31) — Total Capitalization: 986529.00
EMR.V balance_sheet (annual, 2023-12-31) — Total Debt: 26603.00
EMR.V balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 986529.00
EMR.V income_statement (annual, 2023-12-31) — Total Expenses: 1953351.00
EMR.V balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 1931567.00
EMR.V balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 2560798.00
EMR.V balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
EMR.V income_statement (annual, 2023-12-31) — Total Other Finance Cost: 1832.00
EMR.V income_statement (annual, 2023-12-31) — Total Unusual Items: 1094056.00
EMR.V income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 1094056.00
EMR.V balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
EMR.V cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: -49591.00
EMR.V balance_sheet (annual, 2023-12-31) — Working Capital: -1574269.00
EMR.V income_statement (annual, 2023-12-31) — Write Off: 77824.00
EMR.V income_statement (quarterly, 2024-09-30) — Basic Average Shares: 32108670.00
EMR.V income_statement (quarterly, 2024-09-30) — Basic EPS: 0.00
EMR.V cash_flow (quarterly, 2024-09-30) — Capital Expenditure: -98000.00
EMR.V cash_flow (quarterly, 2024-09-30) — Cash Dividends Paid: 0.00
EMR.V cash_flow (quarterly, 2024-09-30) — Cash Flow From Continuing Financing Activities: -4861.00
EMR.V cash_flow (quarterly, 2024-09-30) — Changes In Account Receivables: -5150.00
EMR.V cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 0.00
EMR.V balance_sheet (quarterly, 2024-09-30) — Current Debt: 26996.00
EMR.V balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 26996.00
EMR.V income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 32108670.00
EMR.V income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.00
EMR.V cash_flow (quarterly, 2024-09-30) — Financing Cash Flow: -4861.00
EMR.V cash_flow (quarterly, 2024-09-30) — Gain Loss On Investment Securities: -10547.00
EMR.V cash_flow (quarterly, 2024-09-30) — Interest Paid Cff: 0.00
EMR.V cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 0.00
EMR.V cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 0.00
EMR.V balance_sheet (quarterly, 2024-09-30) — Other Current Borrowings: 26996.00
EMR.V balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 103844.00
EMR.V income_statement (quarterly, 2024-09-30) — Rent And Landing Fees: 6854.00
EMR.V income_statement (quarterly, 2024-09-30) — Rent Expense Supplemental: 6854.00
EMR.V cash_flow (quarterly, 2024-09-30) — Sale Of PPE: 20000.00
EMR.V balance_sheet (quarterly, 2024-09-30) — Total Debt: 26996.00
EMR.V income_statement (quarterly, 2024-09-30) — Total Other Finance Cost: -1136.00
EMR.V income_statement (annual, 2024-12-31) — +Operating Expense: 1142164.00
EMR.V income_statement (quarterly, 2024-12-31) — +Operating Expense: 656938.00
EMR.V income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
EMR.V income_statement (quarterly, 2024-12-31) — +Total Revenue: 0.00
EMR.V balance_sheet (annual, 2024-12-31) — Accounts Payable: 1306229.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 1306229.00
EMR.V balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -124093.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -124093.00
EMR.V cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 30382.00
EMR.V income_statement (annual, 2024-12-31) — Basic Average Shares: 34505449.00
EMR.V income_statement (annual, 2024-12-31) — Basic EPS: -0.02
EMR.V cash_flow (annual, 2024-12-31) — Beginning Cash Position: 224525.00
EMR.V cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 40928.00
EMR.V cash_flow (annual, 2024-12-31) — Capital Expenditure: -168908.00
EMR.V balance_sheet (annual, 2024-12-31) — Capital Stock: 49019229.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Capital Stock: 49019229.00
EMR.V balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 52366.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 52366.00
EMR.V balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 52366.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 52366.00
EMR.V cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 630725.00
EMR.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: 635586.00
EMR.V cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 161092.00
EMR.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: 90000.00
EMR.V cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -963976.00
EMR.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Operating Activities: -709668.00
EMR.V cash_flow (annual, 2024-12-31) — Change In Account Payable: -180488.00
EMR.V cash_flow (annual, 2024-12-31) — Change In Payable: 78347.00
EMR.V cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 78347.00
EMR.V cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: 131689.00
EMR.V cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 10112.00
EMR.V cash_flow (quarterly, 2024-12-31) — Change In Prepaid Assets: -21087.00
EMR.V cash_flow (annual, 2024-12-31) — Change In Receivables: -50651.00
EMR.V cash_flow (quarterly, 2024-12-31) — Change In Receivables: -282290.00
EMR.V cash_flow (annual, 2024-12-31) — Change In Working Capital: 37808.00
EMR.V cash_flow (quarterly, 2024-12-31) — Change In Working Capital: -171688.00
EMR.V cash_flow (annual, 2024-12-31) — Changes In Cash: -172159.00
EMR.V cash_flow (quarterly, 2024-12-31) — Changes In Cash: 11438.00
EMR.V balance_sheet (annual, 2024-12-31) — Common Stock: 49019229.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Common Stock: 49019229.00
EMR.V balance_sheet (annual, 2024-12-31) — Common Stock Equity: 420656.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 420656.00
EMR.V cash_flow (annual, 2024-12-31) — Common Stock Issuance: 657328.00
EMR.V cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 657328.00
EMR.V income_statement (annual, 2024-12-31) — Cost Of Revenue: 7539.00
EMR.V income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 2817.00
EMR.V balance_sheet (annual, 2024-12-31) — Current Assets: 195295.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Current Assets: 195295.00
EMR.V balance_sheet (annual, 2024-12-31) — Current Liabilities: 2315841.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 2315841.00
EMR.V balance_sheet (annual, 2024-12-31) — Current Notes Payable: 0.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Current Notes Payable: 0.00
EMR.V cash_flow (annual, 2024-12-31) — Depreciation: 7539.00
EMR.V cash_flow (quarterly, 2024-12-31) — Depreciation: 2817.00
EMR.V cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 7539.00
EMR.V cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 2817.00
EMR.V cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 7539.00
EMR.V cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 2817.00
EMR.V income_statement (annual, 2024-12-31) — Diluted Average Shares: 75661044.00
EMR.V income_statement (annual, 2024-12-31) — Diluted EPS: -0.02
EMR.V income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -546299.00
EMR.V income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: -291545.00
EMR.V balance_sheet (annual, 2024-12-31) — Dueto Related Parties Current: 491873.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Dueto Related Parties Current: 491873.00
EMR.V income_statement (annual, 2024-12-31) — EBIT: -545333.00
EMR.V income_statement (quarterly, 2024-12-31) — EBIT: -291545.00
EMR.V income_statement (annual, 2024-12-31) — EBITDA: -537794.00
EMR.V income_statement (quarterly, 2024-12-31) — EBITDA: -288728.00
EMR.V cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 0.00
EMR.V cash_flow (annual, 2024-12-31) — End Cash Position: 52366.00
EMR.V cash_flow (quarterly, 2024-12-31) — End Cash Position: 52366.00
EMR.V cash_flow (annual, 2024-12-31) — Financing Cash Flow: 630725.00
EMR.V cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: 635586.00
EMR.V cash_flow (annual, 2024-12-31) — Free Cash Flow: -1132884.00
EMR.V cash_flow (quarterly, 2024-12-31) — Free Cash Flow: -634148.00
EMR.V cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -434239.00
EMR.V cash_flow (quarterly, 2024-12-31) — Gain Loss On Investment Securities: -205052.00
EMR.V income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 554681.00
EMR.V income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 312515.00
EMR.V balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 0.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 0.00
EMR.V income_statement (annual, 2024-12-31) — General And Administrative Expense: 577302.00
EMR.V income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 165796.00
EMR.V balance_sheet (annual, 2024-12-31) — Gross PPE: 2665295.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Gross PPE: 2665295.00
EMR.V income_statement (annual, 2024-12-31) — Gross Profit: -7539.00
EMR.V income_statement (quarterly, 2024-12-31) — Gross Profit: -2817.00
EMR.V income_statement (annual, 2024-12-31) — Insurance And Claims: 30131.00
EMR.V income_statement (quarterly, 2024-12-31) — Insurance And Claims: -6595.00
EMR.V income_statement (annual, 2024-12-31) — Interest Expense: 966.00
EMR.V income_statement (quarterly, 2024-12-31) — Interest Expense: 0.00
EMR.V income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 966.00
EMR.V income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 0.00
EMR.V balance_sheet (annual, 2024-12-31) — Invested Capital: 420656.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Invested Capital: 420656.00
EMR.V cash_flow (annual, 2024-12-31) — Investing Cash Flow: 161092.00
EMR.V cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: 90000.00
EMR.V cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 657328.00
EMR.V cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 657328.00
EMR.V cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
EMR.V cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
EMR.V cash_flow (annual, 2024-12-31) — Long Term Debt Payments: 0.00
EMR.V balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 95012.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 95012.00
EMR.V cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 657328.00
EMR.V cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 657328.00
EMR.V cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -2177.00
EMR.V cash_flow (quarterly, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -392.00
EMR.V income_statement (annual, 2024-12-31) — Net Income: -546299.00
EMR.V income_statement (quarterly, 2024-12-31) — Net Income: -291545.00
EMR.V income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -546299.00
EMR.V income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: -291545.00
EMR.V income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -546299.00
EMR.V income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: -291545.00
EMR.V income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -546299.00
EMR.V income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -291545.00
EMR.V income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -546299.00
EMR.V income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -291545.00
EMR.V cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -546299.00
EMR.V cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: -291545.00
EMR.V income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -546299.00
EMR.V income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: -291545.00
EMR.V income_statement (annual, 2024-12-31) — Net Interest Income: -6504.00
EMR.V income_statement (quarterly, 2024-12-31) — Net Interest Income: -4012.00
EMR.V cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 0.00
EMR.V cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 0.00
EMR.V cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -26603.00
EMR.V cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 0.00
EMR.V income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -6504.00
EMR.V income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -4012.00
EMR.V cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 330000.00
EMR.V balance_sheet (annual, 2024-12-31) — Net PPE: 2541202.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Net PPE: 2541202.00
EMR.V cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -168908.00
EMR.V cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -240000.00
EMR.V cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: -26603.00
EMR.V balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 420656.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 420656.00
EMR.V income_statement (annual, 2024-12-31) — Normalized EBITDA: -1062093.00
EMR.V income_statement (quarterly, 2024-12-31) — Normalized EBITDA: -575341.00
EMR.V income_statement (annual, 2024-12-31) — Normalized Income: -1070598.00
EMR.V income_statement (quarterly, 2024-12-31) — Normalized Income: -578158.00
EMR.V cash_flow (annual, 2024-12-31) — Operating Cash Flow: -963976.00
EMR.V cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: -714148.00
EMR.V cash_flow (annual, 2024-12-31) — Operating Gains Losses: -436416.00
EMR.V cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: -200964.00
EMR.V income_statement (annual, 2024-12-31) — Operating Income: -1149703.00
EMR.V income_statement (quarterly, 2024-12-31) — Operating Income: -659755.00
EMR.V income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
EMR.V income_statement (quarterly, 2024-12-31) — Operating Revenue: 0.00
EMR.V balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 51771157.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 51771157.00
EMR.V balance_sheet (annual, 2024-12-31) — Other Current Assets: 23.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 23.00
EMR.V balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 517739.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 517739.00
EMR.V balance_sheet (annual, 2024-12-31) — Other Equity Interest: 9150057.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Other Equity Interest: 9150057.00
EMR.V income_statement (annual, 2024-12-31) — Other Gand A: 518463.00
EMR.V income_statement (quarterly, 2024-12-31) — Other Gand A: 175583.00
EMR.V income_statement (annual, 2024-12-31) — Other Income Expense: 609908.00
EMR.V income_statement (quarterly, 2024-12-31) — Other Income Expense: 372222.00
EMR.V cash_flow (annual, 2024-12-31) — Other Non Cash Items: -84643.00
EMR.V cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: -90089.00
EMR.V income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 85609.00
EMR.V income_statement (annual, 2024-12-31) — Other Operating Expenses: 529726.00
EMR.V income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 456006.00
EMR.V balance_sheet (annual, 2024-12-31) — Other Properties: 2570283.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Other Properties: 2570283.00
EMR.V balance_sheet (annual, 2024-12-31) — Other Receivables: 3000.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Other Receivables: 3000.00
EMR.V income_statement (annual, 2024-12-31) — Other Taxes: 35136.00
EMR.V balance_sheet (annual, 2024-12-31) — Payables: 1798102.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Payables: 1798102.00
EMR.V balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 1798102.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 1798102.00
EMR.V balance_sheet (annual, 2024-12-31) — Prepaid Assets: 34906.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 34906.00
EMR.V income_statement (annual, 2024-12-31) — Pretax Income: -546299.00
EMR.V income_statement (quarterly, 2024-12-31) — Pretax Income: -291545.00
EMR.V cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
EMR.V cash_flow (annual, 2024-12-31) — Purchase Of PPE: -168908.00
EMR.V cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: 80000.00
EMR.V balance_sheet (annual, 2024-12-31) — Receivables: 108000.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Receivables: 108000.00
EMR.V income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 7539.00
EMR.V income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 2817.00
EMR.V income_statement (annual, 2024-12-31) — Reconciled Depreciation: 7539.00
EMR.V income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 2817.00
EMR.V income_statement (annual, 2024-12-31) — Rent And Landing Fees: 1055.00
EMR.V income_statement (quarterly, 2024-12-31) — Rent And Landing Fees: -10131.00
EMR.V income_statement (annual, 2024-12-31) — Rent Expense Supplemental: 1055.00
EMR.V income_statement (quarterly, 2024-12-31) — Rent Expense Supplemental: -10131.00
EMR.V cash_flow (annual, 2024-12-31) — Repayment Of Debt: 0.00
EMR.V balance_sheet (annual, 2024-12-31) — Retained Earnings: -57748630.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -57748630.00
EMR.V income_statement (annual, 2024-12-31) — Salaries And Wages: 27653.00
EMR.V income_statement (quarterly, 2024-12-31) — Salaries And Wages: 6939.00
EMR.V cash_flow (annual, 2024-12-31) — Sale Of Investment: 0.00
EMR.V cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 0.00
EMR.V income_statement (annual, 2024-12-31) — Selling General And Administration: 577302.00
EMR.V income_statement (quarterly, 2024-12-31) — Selling General And Administration: 165796.00
EMR.V balance_sheet (annual, 2024-12-31) — Share Issued: 51771157.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Share Issued: 51771157.00
EMR.V income_statement (annual, 2024-12-31) — Special Income Charges: -30382.00
EMR.V income_statement (quarterly, 2024-12-31) — Special Income Charges: -25902.00
EMR.V cash_flow (annual, 2024-12-31) — Stock Based Compensation: 27653.00
EMR.V cash_flow (quarterly, 2024-12-31) — Stock Based Compensation: 6939.00
EMR.V balance_sheet (annual, 2024-12-31) — Stockholders Equity: 420656.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 420656.00
EMR.V balance_sheet (annual, 2024-12-31) — Tangible Book Value: 420656.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 420656.00
EMR.V income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
EMR.V income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
EMR.V income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
EMR.V income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.00
EMR.V balance_sheet (annual, 2024-12-31) — Taxes Receivable: 105000.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 105000.00
EMR.V balance_sheet (annual, 2024-12-31) — Total Assets: 2736497.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Total Assets: 2736497.00
EMR.V balance_sheet (annual, 2024-12-31) — Total Capitalization: 420656.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 420656.00
EMR.V balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 420656.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 420656.00
EMR.V income_statement (annual, 2024-12-31) — Total Expenses: 1149703.00
EMR.V income_statement (quarterly, 2024-12-31) — Total Expenses: 659755.00
EMR.V balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 2315841.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 2315841.00
EMR.V balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 2541202.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 2541202.00
EMR.V balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
EMR.V income_statement (annual, 2024-12-31) — Total Other Finance Cost: 5538.00
EMR.V income_statement (quarterly, 2024-12-31) — Total Other Finance Cost: 4012.00
EMR.V income_statement (annual, 2024-12-31) — Total Unusual Items: 524299.00
EMR.V income_statement (quarterly, 2024-12-31) — Total Unusual Items: 286613.00
EMR.V income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 524299.00
EMR.V income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 286613.00
EMR.V cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
EMR.V cash_flow (quarterly, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
EMR.V balance_sheet (annual, 2024-12-31) — Working Capital: -2120546.00
EMR.V balance_sheet (quarterly, 2024-12-31) — Working Capital: -2120546.00
EMR.V income_statement (annual, 2024-12-31) — Write Off: 30382.00
EMR.V income_statement (quarterly, 2025-03-31) — +Operating Expense: 127855.00
EMR.V income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1319601.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -125593.00
EMR.V income_statement (quarterly, 2025-03-31) — Basic Average Shares: 51771157.00
EMR.V income_statement (quarterly, 2025-03-31) — Basic EPS: 0.00
EMR.V cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 52366.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Capital Stock: 49019229.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 51260.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 51260.00
EMR.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 0.00
EMR.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 0.00
EMR.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -1106.00
EMR.V cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 13372.00
EMR.V cash_flow (quarterly, 2025-03-31) — Change In Payable: 78645.00
EMR.V cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 78645.00
EMR.V cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 6577.00
EMR.V cash_flow (quarterly, 2025-03-31) — Change In Receivables: -743.00
EMR.V cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 84479.00
EMR.V cash_flow (quarterly, 2025-03-31) — Changes In Cash: -1106.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Common Stock: 49019229.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 776326.00
EMR.V cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
EMR.V cash_flow (quarterly, 2025-03-31) — Common Stock Payments: 0.00
EMR.V income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1500.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Current Assets: 188355.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1876747.00
EMR.V cash_flow (quarterly, 2025-03-31) — Depreciation: 1500.00
EMR.V cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 1500.00
EMR.V cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 1500.00
EMR.V income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 51771157.00
EMR.V income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.00
EMR.V income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -129380.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Dueto Related Parties Current: 557146.00
EMR.V income_statement (quarterly, 2025-03-31) — EBIT: -129355.00
EMR.V income_statement (quarterly, 2025-03-31) — EBITDA: -127855.00
EMR.V cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 0.00
EMR.V cash_flow (quarterly, 2025-03-31) — End Cash Position: 51260.00
EMR.V cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 0.00
EMR.V cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -1106.00
EMR.V income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -25.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -32689.00
EMR.V income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 76066.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Gross PPE: 2590311.00
EMR.V income_statement (quarterly, 2025-03-31) — Gross Profit: -1500.00
EMR.V income_statement (quarterly, 2025-03-31) — Insurance And Claims: 3845.00
EMR.V income_statement (quarterly, 2025-03-31) — Interest Expense: 0.00
EMR.V income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 0.00
EMR.V income_statement (quarterly, 2025-03-31) — Interest Income: 0.00
EMR.V income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 0.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Invested Capital: 776326.00
EMR.V cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 0.00
EMR.V cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 95012.00
EMR.V cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
EMR.V cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 42295.00
EMR.V income_statement (quarterly, 2025-03-31) — Net Income: -129380.00
EMR.V income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -129380.00
EMR.V income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -129380.00
EMR.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -129380.00
EMR.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -129380.00
EMR.V cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -129380.00
EMR.V income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -129380.00
EMR.V income_statement (quarterly, 2025-03-31) — Net Interest Income: 0.00
EMR.V cash_flow (quarterly, 2025-03-31) — Net Investment Properties Purchase And Sale: 0.00
EMR.V income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 0.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Net PPE: 2464718.00
EMR.V cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 0.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 776326.00
EMR.V income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -127830.00
EMR.V income_statement (quarterly, 2025-03-31) — Normalized Income: -129355.00
EMR.V cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -1106.00
EMR.V cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 42295.00
EMR.V income_statement (quarterly, 2025-03-31) — Operating Income: -129355.00
EMR.V income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 51771157.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Other Current Assets: -234.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -32689.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 9667796.00
EMR.V income_statement (quarterly, 2025-03-31) — Other Gand A: 72221.00
EMR.V income_statement (quarterly, 2025-03-31) — Other Income Expense: -25.00
EMR.V income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 34668.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Other Properties: 2495299.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Other Receivables: 3000.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Payables: 1876747.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 1876747.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 28329.00
EMR.V income_statement (quarterly, 2025-03-31) — Pretax Income: -129380.00
EMR.V cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
EMR.V cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: 0.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Receivables: 109000.00
EMR.V income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1500.00
EMR.V income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 1500.00
EMR.V cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: 0.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -57878010.00
EMR.V income_statement (quarterly, 2025-03-31) — Salaries And Wages: 0.00
EMR.V cash_flow (quarterly, 2025-03-31) — Sale Of Investment Properties: 0.00
EMR.V income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 17121.00
EMR.V income_statement (quarterly, 2025-03-31) — Selling General And Administration: 93187.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Share Issued: 51771157.00
EMR.V income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
EMR.V cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 0.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 776326.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 776326.00
EMR.V income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
EMR.V income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 106000.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Total Assets: 2653073.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 776326.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 776326.00
EMR.V income_statement (quarterly, 2025-03-31) — Total Expenses: 129355.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1876747.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 2464718.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
EMR.V income_statement (quarterly, 2025-03-31) — Total Unusual Items: -25.00
EMR.V income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -25.00
EMR.V cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: 0.00
EMR.V balance_sheet (quarterly, 2025-03-31) — Working Capital: -1688392.00
EMR.V income_statement (quarterly, 2025-06-30) — +Operating Expense: 149282.00
EMR.V income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1416682.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -127093.00
EMR.V income_statement (quarterly, 2025-06-30) — Basic Average Shares: 51771157.00
EMR.V income_statement (quarterly, 2025-06-30) — Basic EPS: 0.00
EMR.V cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 51260.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Capital Stock: 49019229.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 17534.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 17534.00
EMR.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 35000.00
EMR.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -68726.00
EMR.V cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 31808.00
EMR.V cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 10162.00
EMR.V cash_flow (quarterly, 2025-06-30) — Change In Receivables: 106504.00
EMR.V cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 148474.00
EMR.V cash_flow (quarterly, 2025-06-30) — Changes In Cash: -33726.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Common Stock: 49019229.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 596597.00
EMR.V income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1500.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Current Assets: 156762.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 2027354.00
EMR.V cash_flow (quarterly, 2025-06-30) — Depreciation: 1500.00
EMR.V cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 1500.00
EMR.V cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 1500.00
EMR.V income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 51771157.00
EMR.V income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.00
EMR.V income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -151218.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Current: 610672.00
EMR.V income_statement (quarterly, 2025-06-30) — EBIT: -151218.00
EMR.V income_statement (quarterly, 2025-06-30) — EBITDA: -149718.00
EMR.V cash_flow (quarterly, 2025-06-30) — End Cash Position: 17534.00
EMR.V cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -68726.00
EMR.V income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 138.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -61200.00
EMR.V income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 104972.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Gross PPE: 2594282.00
EMR.V income_statement (quarterly, 2025-06-30) — Gross Profit: -1500.00
EMR.V income_statement (quarterly, 2025-06-30) — Insurance And Claims: 5642.00
EMR.V income_statement (quarterly, 2025-06-30) — Interest Expense: 0.00
EMR.V income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 0.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Invested Capital: 596597.00
EMR.V cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 35000.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 95012.00
EMR.V cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -67482.00
EMR.V income_statement (quarterly, 2025-06-30) — Net Income: -151218.00
EMR.V income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -151218.00
EMR.V income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -151218.00
EMR.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -151218.00
EMR.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -151218.00
EMR.V cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -151218.00
EMR.V income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -151218.00
EMR.V income_statement (quarterly, 2025-06-30) — Net Interest Income: -574.00
EMR.V income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -574.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Net PPE: 2467189.00
EMR.V cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: 0.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 596597.00
EMR.V income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -149856.00
EMR.V income_statement (quarterly, 2025-06-30) — Normalized Income: -151356.00
EMR.V cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -68726.00
EMR.V cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -67482.00
EMR.V income_statement (quarterly, 2025-06-30) — Operating Income: -150782.00
EMR.V income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 51771157.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 61.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -61200.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 9667796.00
EMR.V income_statement (quarterly, 2025-06-30) — Other Gand A: 90775.00
EMR.V income_statement (quarterly, 2025-06-30) — Other Income Expense: 138.00
EMR.V income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 44310.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Other Properties: 2499270.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Other Receivables: 7000.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Payables: 2027354.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 2027354.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 18167.00
EMR.V income_statement (quarterly, 2025-06-30) — Pretax Income: -151218.00
EMR.V cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: 0.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Receivables: 121000.00
EMR.V income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1500.00
EMR.V income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 1500.00
EMR.V income_statement (quarterly, 2025-06-30) — Rent And Landing Fees: 8555.00
EMR.V income_statement (quarterly, 2025-06-30) — Rent Expense Supplemental: 8555.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -58029228.00
EMR.V income_statement (quarterly, 2025-06-30) — Salaries And Wages: 0.00
EMR.V income_statement (quarterly, 2025-06-30) — Selling General And Administration: 104972.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Share Issued: 51771157.00
EMR.V income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
EMR.V cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 0.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 596597.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 596597.00
EMR.V income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
EMR.V income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 114000.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Total Assets: 2623951.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 596597.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 596597.00
EMR.V income_statement (quarterly, 2025-06-30) — Total Expenses: 150782.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 2027354.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 2467189.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
EMR.V income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 574.00
EMR.V income_statement (quarterly, 2025-06-30) — Total Unusual Items: 138.00
EMR.V income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 138.00
EMR.V balance_sheet (quarterly, 2025-06-30) — Working Capital: -1870592.00
EMR.V income_statement (quarterly, 2025-09-30) — +Operating Expense: 199982.00
EMR.V income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 769420.00
EMR.V balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -130083.00
EMR.V income_statement (quarterly, 2025-09-30) — Basic Average Shares: 51771157.00
EMR.V income_statement (quarterly, 2025-09-30) — Basic EPS: 0.01
EMR.V cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 17534.00